We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current PAA market cap is 111.32M. The company's latest EPS is AUD -0.0159 and P/E is -17.61.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 4.35M | 4.12M | 3.66M | 4.51M | 3.82M |
| Operating Income | -1.52M | -1.25M | -1.27M | -1.62M | -5.58M |
| Net Income | -1.55M | -1.36M | -1.34M | -1.71M | -6.21M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 8.6M | 10.75M | 10.95M | 10.08M | 6.13M |
| Total Liabilities | 1.14M | 2.22M | 2.07M | 2.23M | 2.24M |
| Total Equity | 7.46M | 8.53M | 8.88M | 7.84M | 3.89M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -1.55M | -1.27M | -938k | -1.33M | -1.56M |
| Investing | -147k | -30k | -138k | -43k | -35k |
| Financing | 1.92M | 2.09M | 1.22M | 771k | 1.89M |
| Market Cap | 111.32M |
| Price to Earnings Ratio | -17.61 |
| Price to Sales Ratio | 28.57 |
| Price to Cash Ratio | 40.58 |
| Price to Book Ratio | 28.12 |
| Dividend Yield | - |
| Shares Outstanding | 390.59M |
| Average Volume (1 week) | 592.57k |
| Average Volume (1 Month) | 732.84k |
| 52 Week Change | 171.43% |
| 52 Week High | 0.535 |
| 52 Week Low | 0.0655 |
| Spread (Intraday) | 0.01 (3.39%) |
| Company Name | Pharmaust Limited |
| Address |
suite 116 perth, western australia 6010 |
| Website | https://www.pharmaust.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
